Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
종목 코드 MYO
회사 이름Myomo Inc
상장일Jun 12, 2017
CEOMr. Paul R. Gudonis
직원 수184
유형Ordinary Share
회계 연도 종료Jun 12
주소137 Portland Street
도시BOSTON
증권 거래소NYSE American Consolidated
국가United States of America
우편 번호02114
전화16179969058
웹사이트https://myomo.com/
종목 코드 MYO
상장일Jun 12, 2017
CEOMr. Paul R. Gudonis
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음